A strong case for third-party testing
eLife · 14.11.2023 · 12
DOI: 10.7554/elife.93329 ↗Kurz gefasst
Editorial in der Zeitschrift eLife, online erschienen am 14.11.2023. Verfasst von Fridtjof Lund-Johansen. Beteiligte Einrichtung: Department of Immunology, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Antibodies. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Oslo University Hospital, Oslo, Norway.
ORCID-Profile: Fridtjof Lund-Johansen
Zitieren
APA
Lund-Johansen, F. (2023). A strong case for third-party testing. eLife, 12. https://doi.org/10.7554/elife.93329
Vancouver
Lund-Johansen F. A strong case for third-party testing. eLife. 2023;12. doi:10.7554/elife.93329
BibTeX
@article{LundJohansen2023,
author = {Lund-Johansen, Fridtjof},
title = {A strong case for third-party testing},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.93329}
}
EUVIMED